Chinese Vitamin C Makers Win Dismissal of $147 Million JudgmentBy
North China Pharmaceutical and Hebei Welcome win U.S. ruling
Companies can’t be held liable for price fixing, court says
Two Chinese drug companies won dismissal of a $147 million antitrust verdict after a federal appeals court ruled they were acting under Chinese law and couldn’t be held liable in the U.S. for fixing prices.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.